https://twitter.com/uTobian/status/1271328850702557186

University of Michigan - Ann Arbor

A tweet makes the claim that the biopharmaceutical company Gilead is responsible for influencing studies to publish papers to say that HCQ is ineffective so that they can continue to develop and sell Remdesivir, an FDA approved treatment for COVID-19. 

Learn Before

Related